Leukogene Therapeutics has received orphan drug designation from the US FDA for M2T-CD33 (LTI-214), its immunotherapy candidate targeting AML.

Government officials use Gmail and ordinary phones without basic security consciousness.' 'Interoperability, especially in ...

It has the largest mouth of any animal and uses its truck-sized curved head to batter through Arctic ice to surface from the depths.And while swimming in freezing waters and smashing cranium-first up ...

The UK’s first NHS National Rehabilitation Centre is preparing to open its doors in Nottinghamshire, marking a major milestone i ...